BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23337140)

  • 1. Primary hyperparathyroidism is associated with subclinical peripheral neural alterations.
    Diniz ET; Bandeira F; Lins OG; Cavalcanti ÉN; de Arruda TM; Januário AM; Diniz KT; Marques TF; Azevedo H
    Endocr Pract; 2013; 19(2):219-25. PubMed ID: 23337140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system in elderly people.
    Vrancken AF; Franssen H; Wokke JH; Teunissen LL; Notermans NC
    Arch Neurol; 2002 Apr; 59(4):533-40. PubMed ID: 11939887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between electroneurographic changes and serum ubiquitin levels in patients with type 2 diabetes.
    Akarsu E; Pirim I; Capoğlu I; Deniz O; Akçay G; Unüvar N
    Diabetes Care; 2001 Jan; 24(1):100-3. PubMed ID: 11194212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic lithium treatment on the peripheral nervous system.
    Faravelli C; Di Bernardo M; Ricca V; Benvenuti P; Bartelli M; Ronchi O
    J Clin Psychiatry; 1999 May; 60(5):306-10. PubMed ID: 10362438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subclinical lesions of peripheral nervous system in multiple sclerosis patients].
    Pogorzelski R; Baniukiewicz E; Drozdowski W
    Neurol Neurochir Pol; 2004; 38(4):257-64. PubMed ID: 15383952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medial dorsal superficial peroneal nerve studies in patients with polyneuropathy and normal sural responses.
    Kushnir M; Klein C; Kimiagar Y; Pollak L; Rabey JM
    Muscle Nerve; 2005 Mar; 31(3):386-9. PubMed ID: 15508123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
    Verheyen N; Fahrleitner-Pammer A; Pieske B; Meinitzer A; Belyavskiy E; Wetzel J; Gaksch M; Grübler MR; Catena C; Sechi LA; Van Ballegooijen AJ; Brandenburg VM; Scharnagl H; Perl S; Brussee H; März W; Pilz S; Tomaschitz A
    J Hypertens; 2016 Sep; 34(9):1778-86. PubMed ID: 27379537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of sensory evoked potentials in the diagnosis of polyneuropathy].
    Vogel P
    Fortschr Neurol Psychiatr; 1986 Oct; 54(10):305-17. PubMed ID: 3792983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels.
    Lim V; Clarke BL
    J Clin Endocrinol Metab; 2013 May; 98(5):1939-45. PubMed ID: 23493435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve conduction study of healthy Asian Malays: the influence of age on median, ulnar, and sural nerves.
    Awang MS; Abdullah JM; Abdullah MR; Tahir A; Tharakan J; Prasad A; Razak SA
    Med Sci Monit; 2007 Jul; 13(7):CR330-2. PubMed ID: 17599028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyneuropathy associated with chronic hemodialysis: Clinical and electrophysiological study.
    Ezzeldin N; Abdel Galil SM; Said D; Kamal NM; Amer M
    Int J Rheum Dis; 2019 May; 22(5):826-833. PubMed ID: 30575307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyneuropathy in diabetic and nondiabetic patients on CAPD: is there an association with HRQOL?
    Jovanovic DB; Matanovic DD; Simic-Ogrizovic SP; Stosovic MD; Bontic AC; Nesic VD
    Perit Dial Int; 2009; 29(1):102-7. PubMed ID: 19164259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
    Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
    Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greater than age-predicted functional deficits in older patients with primary hyperparathyroidism.
    Morris GS; Landry CL; Grubbs EG; Jimenez C; Busaidy NL; Perrier ND
    Endocr Pract; 2012; 18(4):450-5. PubMed ID: 22784831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High serum parathyroid hormone and calcium are risk factors for hypertension in Japanese patients.
    Yagi S; Aihara K; Kondo T; Endo I; Hotchi J; Ise T; Iwase T; Akaike M; Matsumoto T; Sata M
    Endocr J; 2014; 61(7):727-33. PubMed ID: 24849536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tibial motor and sural electrophysiological relationship in subjects without and patients with mild axonal peripheral neuropathy.
    Julian TH; Sarrigiannis PG; Girach A; Zis P
    Acta Neurol Belg; 2020 Jun; 120(3):677-680. PubMed ID: 31686383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT).
    Salinas M; López-Garrigós M; Pomares F; Lugo J; Asencio A; López-Penabad L; Dominguez JR; Leiva-Salinas C
    Bone; 2013 Sep; 56(1):73-6. PubMed ID: 23707628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record.
    Press DM; Siperstein AE; Berber E; Shin JJ; Metzger R; Monteiro R; Mino J; Swagel W; Mitchell JC
    Surgery; 2013 Dec; 154(6):1232-7; discussion 1237-8. PubMed ID: 24383100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
    Palermo A; Naciu AM; Tabacco G; Falcone S; Santonati A; Maggi D; D'Onofrio L; Briganti SI; Castellitto D; Casini A; Pedone C; Lelli D; Fabbri A; Bilezikian JP; Napoli N; Pozzilli P; Manfrini S; Cesareo R
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.